Center news & funding
Susan Hong, M.D., M.P.H., FACP, joined VCU Massey Cancer Center and VCU Health in January as the director of the Cancer Survivorship Program. She also holds the RGC Professorship in Cancer Research and is an associate professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine.
This week, VCU Massey Cancer Center and VCU Health System welcomed Katie Barnes, MPA, as vice president of the Cancer Service Line. The Cancer Service Line is a new collaborative model designed to fulfill strategic initiatives for Massey while maintaining close alignment with VCU Health System.
VCU Massey Cancer Center researcher John Hackett, Ph.D., is at the forefront of integrating computer simulations with laboratory experiments to understand complex biological systems at the molecular level. His work has tremendous implications for the development of drugs to treat a range of diseases and is so significant that the National Institutes of Health has funded his team for more than a decade. Earlier this year, Hackett received a four-year, $1.5 million R01 grant from the National Institute of General Medical Sciences (NIGMS) to unlock the secrets of cytochromes P450 (CYPs).
VCU Massey Cancer Center researcher Larisa Litovchick, M.D., Ph.D., was recently awarded $465,000 from the National Institute of Dental and Cranial Research to further investigate how human papillomavirus (HPV) leads to head and neck cancers. Findings may aid the development of novel targeted treatments.
$2.3 million grant from the National Cancer Institute funds new viral-based gene therapies for lung cancer at Massey
Mutations in the p53 gene are found in more than half of all cancers, yet it has proven to be very difficult to target the gene with therapeutic drugs even 40 years after its discovery. VCU Massey Cancer Center researchers Sumitra Deb, Ph.D., and Brad Windle, Ph.D., are hoping to turn the tide with an innovative viral-based strategy, and they recently received more than $2 million from the National Cancer Institute to fund their work.